EMEA (Europe, Middle East and Africa) Pet Vaccine Market Report 2018

February 2018 | 107 pages | ID: EA836E9D3D6EN
QYResearch

Abstracts

In this report, the EMEA Pet Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Pet Vaccine for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pet Vaccine market competition by top manufacturers/players, with Pet Vaccine sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer Healthcare
• Vetoquinol S.A
• Boehringer Ingelheim
• Ceva
• Eli Lilly
• Heska Co.
• Merck Animal Health
• Merial (Sanofi)
• Virbac
• Zoetis (Pfizer)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Canine
• Avian
• Feline

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Pet Vaccine Market Report 2018

1 PET VACCINE OVERVIEW

1.1 Product Overview and Scope of Pet Vaccine
1.2 Classification of Pet Vaccine
  1.2.1 EMEA Pet Vaccine Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Pet Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Attenuated Live Vaccines
  1.2.4 Conjugate Vaccines
  1.2.5 Inactivated Vaccines
  1.2.6 Subunit Vaccines
  1.2.7 Toxoid Vaccines
  1.2.8 DNA Vaccines
  1.2.9 Recombinant Vaccines
1.3 EMEA Pet Vaccine Market by Application/End Users
  1.3.1 EMEA Pet Vaccine Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Canine
  1.3.3 Avian
  1.3.4 Feline
1.4 EMEA Pet Vaccine Market by Region
  1.4.1 EMEA Pet Vaccine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Pet Vaccine (2013-2025)
  1.5.1 EMEA Pet Vaccine Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Pet Vaccine Revenue and Growth Rate (2013-2025)

2 EMEA PET VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Pet Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Pet Vaccine Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Pet Vaccine Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Pet Vaccine Sale Price by Players (2013-2018)
2.2 EMEA Pet Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Pet Vaccine Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Pet Vaccine Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Pet Vaccine Sale Price by Type (2013-2018)
2.3 EMEA Pet Vaccine (Volume) by Application
2.4 EMEA Pet Vaccine (Volume and Value) by Region
  2.4.1 EMEA Pet Vaccine Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Pet Vaccine Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Pet Vaccine Sales Price by Region (2013-2018)

3 EUROPE PET VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Pet Vaccine Sales and Value (2013-2018)
  3.1.1 Europe Pet Vaccine Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Pet Vaccine Revenue and Growth Rate (2013-2018)
3.2 Europe Pet Vaccine Sales and Market Share by Type
3.3 Europe Pet Vaccine Sales and Market Share by Application
3.4 Europe Pet Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Pet Vaccine Sales Volume by Countries (2013-2018)
  3.4.2 Europe Pet Vaccine Revenue by Countries (2013-2018)
  3.4.3 Germany Pet Vaccine Sales and Growth Rate (2013-2018)
  3.4.4 France Pet Vaccine Sales and Growth Rate (2013-2018)
  3.4.5 UK Pet Vaccine Sales and Growth Rate (2013-2018)
  3.4.6 Russia Pet Vaccine Sales and Growth Rate (2013-2018)
  3.4.7 Italy Pet Vaccine Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Pet Vaccine Sales and Growth Rate (2013-2018)

4 MIDDLE EAST PET VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Pet Vaccine Sales and Value (2013-2018)
  4.1.1 Middle East Pet Vaccine Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Pet Vaccine Revenue and Growth Rate (2013-2018)
4.2 Middle East Pet Vaccine Sales and Market Share by Type
4.3 Middle East Pet Vaccine Sales and Market Share by Application
4.4 Middle East Pet Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Pet Vaccine Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Pet Vaccine Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Pet Vaccine Sales and Growth Rate (2013-2018)
  4.4.4 Israel Pet Vaccine Sales and Growth Rate (2013-2018)
  4.4.5 UAE Pet Vaccine Sales and Growth Rate (2013-2018)
  4.4.6 Iran Pet Vaccine Sales and Growth Rate (2013-2018)

5 AFRICA PET VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Pet Vaccine Sales and Value (2013-2018)
  5.1.1 Africa Pet Vaccine Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Pet Vaccine Revenue and Growth Rate (2013-2018)
5.2 Africa Pet Vaccine Sales and Market Share by Type
5.3 Africa Pet Vaccine Sales and Market Share by Application
5.4 Africa Pet Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Pet Vaccine Sales Volume by Countries (2013-2018)
  5.4.2 Africa Pet Vaccine Revenue by Countries (2013-2018)
  5.4.3 South Africa Pet Vaccine Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Pet Vaccine Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Pet Vaccine Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Pet Vaccine Sales and Growth Rate (2013-2018)

6 EMEA PET VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bayer Healthcare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pet Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Vetoquinol S.A
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Pet Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Pet Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Ceva
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Pet Vaccine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ceva Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Pet Vaccine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eli Lilly Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Heska Co.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Pet Vaccine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Heska Co. Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Merck Animal Health
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Pet Vaccine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Merial (Sanofi)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Pet Vaccine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Virbac
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Pet Vaccine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Virbac Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Zoetis (Pfizer)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Pet Vaccine Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 PET VACCINE MANUFACTURING COST ANALYSIS

7.1 Pet Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pet Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pet Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pet Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PET VACCINE MARKET FORECAST (2018-2025)

11.1 EMEA Pet Vaccine Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Pet Vaccine Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Pet Vaccine Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Pet Vaccine Price and Trend Forecast (2018-2025)
11.2 EMEA Pet Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Pet Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Pet Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Pet Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Pet Vaccine Sales Forecast by Type (2018-2025)
11.7 EMEA Pet Vaccine Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pet Vaccine
Figure EMEA Pet Vaccine Sales Volume (K Doses) by Type (2013-2025)
Figure EMEA Pet Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Attenuated Live Vaccines Product Picture
Figure Conjugate Vaccines Product Picture
Figure Inactivated Vaccines Product Picture
Figure Subunit Vaccines Product Picture
Figure Toxoid Vaccines Product Picture
Figure DNA Vaccines Product Picture
Figure Recombinant Vaccines Product Picture
Figure EMEA Pet Vaccine Sales Volume (K Doses) by Application (2013-2025)
Figure EMEA Sales Market Share of Pet Vaccine by Application in 2017
Figure Canine Examples
Table Key Downstream Customer in Canine
Figure Avian Examples
Table Key Downstream Customer in Avian
Figure Feline Examples
Table Key Downstream Customer in Feline
Figure EMEA Pet Vaccine Market Size (Million USD) by Region (2013-2025)
Figure Europe Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Pet Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Pet Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Pet Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pet Vaccine Sales Volume and Growth Rate (2013-2025)
Figure EMEA Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Pet Vaccine Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table EMEA Pet Vaccine Sales Volume (K Doses) of Major Players (2013-2018)
Table EMEA Pet Vaccine Sales Share by Players (2013-2018)
Figure 2017 Pet Vaccine Sales Share by Players
Figure 2017 Pet Vaccine Sales Share by Players
Figure EMEA Pet Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Pet Vaccine Revenue (Million USD) by Players (2013-2018)
Table EMEA Pet Vaccine Revenue Share by Players (2013-2018)
Table 2017 EMEA Pet Vaccine Revenue Share by Players
Table 2017 EMEA Pet Vaccine Revenue Share by Players
Table EMEA Pet Vaccine Sale Price (USD/Dose) by Players (2013-2018)
Table EMEA Pet Vaccine Sales (K Doses) and Market Share by Type (2013-2018)
Table EMEA Pet Vaccine Sales Share by Type (2013-2018)
Figure Sales Market Share of Pet Vaccine by Type (2013-2018)
Figure EMEA Pet Vaccine Sales Market Share by Type (2013-2018)
Table EMEA Pet Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Pet Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Pet Vaccine by Type in 2017
Table EMEA Pet Vaccine Sale Price (USD/Dose) by Type (2013-2018)
Table EMEA Pet Vaccine Sales (K Doses) and Market Share by Application (2013-2018)
Table EMEA Pet Vaccine Sales Share by Application (2013-2018)
Figure Sales Market Share of Pet Vaccine by Application (2013-2018)
Figure EMEA Pet Vaccine Sales Market Share by Application in 2017
Table EMEA Pet Vaccine Sales (K Doses) and Market Share by Region (2013-2018)
Table EMEA Pet Vaccine Sales Share by Region (2013-2018)
Figure Sales Market Share of Pet Vaccine by Region (2013-2018)
Figure EMEA Pet Vaccine Sales Market Share in 2017
Table EMEA Pet Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Pet Vaccine Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Pet Vaccine by Region (2013-2018)
Figure EMEA Pet Vaccine Revenue Market Share Regions in 2017
Table EMEA Pet Vaccine Sales Price (USD/Dose) by Region (2013-2018)
Figure Europe Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Europe Pet Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Pet Vaccine Sales (K Doses) by Type (2013-2018)
Table Europe Pet Vaccine Market Share by Type (2013-2018)
Figure Europe Pet Vaccine Market Share by Type in 2017
Table Europe Pet Vaccine Sales (K Doses) by Application (2013-2018)
Table Europe Pet Vaccine Market Share by Application (2013-2018)
Figure Europe Pet Vaccine Market Share by Application in 2017
Table Europe Pet Vaccine Sales (K Doses) by Countries (2013-2018)
Table Europe Pet Vaccine Sales Market Share by Countries (2013-2018)
Figure Europe Pet Vaccine Sales Market Share by Countries (2013-2018)
Figure Europe Pet Vaccine Sales Market Share by Countries in 2017
Table Europe Pet Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Europe Pet Vaccine Revenue Market Share by Countries (2013-2018)
Figure Europe Pet Vaccine Revenue Market Share by Countries (2013-2018)
Figure Europe Pet Vaccine Revenue Market Share by Countries in 2017
Figure Germany Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure France Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure UK Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Russia Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Italy Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Benelux Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Middle East Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Middle East Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Pet Vaccine Sales (K Doses) by Type (2013-2018)
Table Middle East Pet Vaccine Market Share by Type (2013-2018)
Figure Middle East Pet Vaccine Market Share by Type (2013-2018)
Table Middle East Pet Vaccine Sales (K Doses) by Applications (2013-2018)
Table Middle East Pet Vaccine Market Share by Applications (2013-2018)
Figure Middle East Pet Vaccine Sales Market Share by Application in 2017
Table Middle East Pet Vaccine Sales Volume (K Doses) by Countries (2013-2018)
Table Middle East Pet Vaccine Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Pet Vaccine Sales Volume Market Share by Countries in 2017
Table Middle East Pet Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Middle East Pet Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East Pet Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East Pet Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Israel Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure UAE Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Iran Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Africa Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Africa Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Pet Vaccine Sales (K Doses) by Type (2013-2018)
Table Africa Pet Vaccine Sales Market Share by Type (2013-2018)
Figure Africa Pet Vaccine Sales Market Share by Type (2013-2018)
Figure Africa Pet Vaccine Sales Market Share by Type in 2017
Table Africa Pet Vaccine Sales (K Doses) by Application (2013-2018)
Table Africa Pet Vaccine Sales Market Share by Application (2013-2018)
Figure Africa Pet Vaccine Sales Market Share by Application (2013-2018)
Table Africa Pet Vaccine Sales Volume (K Doses) by Countries (2013-2018)
Table Africa Pet Vaccine Sales Market Share by Countries (2013-2018)
Figure Africa Pet Vaccine Sales Market Share by Countries (2013-2018)
Figure Africa Pet Vaccine Sales Market Share by Countries in 2017
Table Africa Pet Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Africa Pet Vaccine Revenue Market Share by Countries (2013-2018)
Figure Africa Pet Vaccine Revenue Market Share by Countries (2013-2018)
Figure Africa Pet Vaccine Revenue Market Share by Countries in 2017
Figure South Africa Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Nigeria Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Egypt Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Algeria Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Table Bayer Healthcare Pet Vaccine Basic Information List
Table Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bayer Healthcare Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Bayer Healthcare Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Bayer Healthcare Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Vetoquinol S.A Pet Vaccine Basic Information List
Table Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Vetoquinol S.A Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Vetoquinol S.A Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Vetoquinol S.A Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Boehringer Ingelheim Pet Vaccine Basic Information List
Table Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Boehringer Ingelheim Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Boehringer Ingelheim Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Ceva Pet Vaccine Basic Information List
Table Ceva Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Ceva Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Ceva Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Ceva Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Eli Lilly Pet Vaccine Basic Information List
Table Eli Lilly Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Eli Lilly Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Eli Lilly Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Heska Co. Pet Vaccine Basic Information List
Table Heska Co. Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Heska Co. Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Heska Co. Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Heska Co. Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Merck Animal Health Pet Vaccine Basic Information List
Table Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Animal Health Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Merck Animal Health Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Merck Animal Health Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Merial (Sanofi) Pet Vaccine Basic Information List
Table Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merial (Sanofi) Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Merial (Sanofi) Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Merial (Sanofi) Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Virbac Pet Vaccine Basic Information List
Table Virbac Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Virbac Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Virbac Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Virbac Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Zoetis (Pfizer) Pet Vaccine Basic Information List
Table Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Zoetis (Pfizer) Pet Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Zoetis (Pfizer) Pet Vaccine Sales Market Share in EMEA (2013-2018)
Figure Zoetis (Pfizer) Pet Vaccine Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pet Vaccine
Figure Manufacturing Process Analysis of Pet Vaccine
Figure Pet Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pet Vaccine Major Manufacturers in 2017
Table Major Buyers of Pet Vaccine
Table Distributors/Traders List
Figure EMEA Pet Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure EMEA Pet Vaccine Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Pet Vaccine Price (USD/Dose) and Trend Forecast (2018-2025)
Table EMEA Pet Vaccine Sales (K Doses) Forecast by Region (2018-2025)
Figure EMEA Pet Vaccine Sales Market Share Forecast by Region (2018-2025)
Table EMEA Pet Vaccine Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Pet Vaccine Revenue Market Share Forecast by Region (2018-2025)
Table Europe Pet Vaccine Sales (K Doses) Forecast by Countries (2018-2025)
Figure Europe Pet Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Europe Pet Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Pet Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Pet Vaccine Sales (K Doses) Forecast by Countries (2018-2025)
Figure Middle East Pet Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Pet Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Pet Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Pet Vaccine Sales (K Doses) Forecast by Countries (2018-2025)
Figure Africa Pet Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Africa Pet Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Pet Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Pet Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure EMEA Pet Vaccine Sales Market Share Forecast by Type (2018-2025)
Table EMEA Pet Vaccine Sales (K Doses) Forecast by Application (2018-2025)
Figure EMEA Pet Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources